Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • CommuniquĂ© 53 Cover Image

    • OPEN Health Group Appoints New Leadership

    November 18, 2020 |  

    OPEN Health Group today announced that Rob Barker has been appointed Chief Executive Officer. Rob succeeds outgoing CEO and Co-Founder, David Rowley, who is stepping down after 10 years. A portfolio company of Amulet Capital Partners, LP, OPEN Health is a leading multi-disciplinary health communications and market access group.

    Mr. Barker has approximately 30 years of executive leadership experience in the biopharmaceuticals industry, including multiple roles at leading medical communications and strategy consulting firms. Most recently, he served as CEO of OPEN Health’s Medical Communications practice, having joined the business six years ago.

    Mr. Barker expressed his enthusiasm for the continued growth and success of OPEN Health: “I am excited to be leading such a talented and expert team who have been instrumental in growing OPEN Health to its current position. We are now in a place to take even greater strides forward, and I feel confident that our continued focus on client service and scientific excellence will drive increased growth in the business.”

    “Rob Barker has proven himself as an outstanding strategic and operational leader, and we are confident that he is the ideal executive to lead OPEN Health through its next exciting stage of growth,” said Ramsey Frank, Managing Partner and co-founder of Amulet. Amulet Partner Nick Amigone added, “Medical Affairs, Medical Communications, Market Access and HEOR have taken on increasingly important roles in bringing new therapies to market. Rob has been instrumental in assembling a suite of best-in-class capabilities at OPEN Health and driving the business to achieve its full potential.”

    Mr. Frank added, “David Rowley leaves the business with our enormous thanks. He has grown OPEN Health from an initial idea to a leading global healthcare communications group. All his colleagues at OPEN Health are grateful to him and wish him well for the future. David will work with us in an advisory capacity to ensure a smooth transition.”

    Mr. Rowley said “I have been CEO of OPEN Health since its inception, and I am incredibly proud of the company that we have built. This is the right time for me to be stepping down, and I wish Rob and the whole OPEN Health team continued success.”

    Pink divider

    About OPEN Health

    OPEN Health is a multi-disciplinary health communications and market access group, operating across three core business areas: Medical Communications; Patient and Brand Communications; and Value, Informatics and Evidence. OPEN Health was formed in 2011, and whilst working across a broad therapeutic range has a strong focus on oncology, rare diseases and specialist medicines.

    For more information on OPEN Health, please visit www.openhealthgroup.com.

    About Amulet Capital Partners, LP

    Amulet Capital Partners, LP is a middle-market private equity investment firm based in Greenwich, CT, focused exclusively on the healthcare sector. Amulet seeks to achieve long-term capital appreciation through privately negotiated investments in companies. Amulet Capital Partners focuses on those segments it believes have the most attractive long-term fundamentals with a target investment size generally between $25 million to $150 million.

    For additional information, please visit www.amuletcapital.com.

    Pink divider

    Contacts for OPEN Health:

    EU: Carwyn Jones 
    carwynjones@openhealthgroup.com
    +44 20 3386 4728

    USA: Candice Subero
    csubero@openhealthgroup.com
    +1 240-483-4323

    Contact for Amulet Capital Partners:

    Melissa Sheer 
    melissa@kentplacellc.com
    +1 917-690-2199

    This content was provided by OPEN Health

    Company Details

    OPEN Health

    OPEN Health

    Email
    Website

     Latest Content from  OPEN Health 

    OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa

    Ben Speller shares his thoughts on the value of disease specific congresses

    OPEN Health use PR to support clinical trial recruitment

    International Clinical Trials Day finds clinical research in the spotlight like never before, with any news coming from the many studies into potential vaccines and treatments for SARS-CoV-2

    OPEN Health | European Congress on Rare Diseases (ECRD) 2020 in 60 seconds

    Gavin Jones, Director or Rare Disease, attends the congress to better understand the viewpoints of patient groups, health systems and payers

    OPEN Health attend day 2 of the ECRD2020 congress

    Gavin Jones is looking forward to sessions on innovation in advanced therapies and working towards equitable access.

    OPEN Health continued support for My Name’5 Doddie

    Charity fundraising for Motor Neuron Disease

    OPEN Health’s latest partnership with Rare Revolution Magazine

    Richard Jones introduces our Head of Health Psychology (Dr Sumira Riaz)

    OPEN Health CSR Report 2019

    Margot Hannah, Partner and Group Managing Director, and CSR lead at OPEN Health shares her thoughts on our latest report.

    OPEN Health at ECRD 2020

    Gavin Jones shares his thoughts on why congress is so important at this time and the key sessions he is looking forward to.

    OPEN Health discuss Global Community in Rare Disease

    Annie Rankin how we can work smarter with healthcare professionals

    OPEN Health Patient & Brand Communications highly commended finalist

    Shortlisted for Best Patient-Centric Approach for 2020 BOBI Awards.